indications for CMV seronegative blood products

Introduction

for CMV seronegative patients

Indications

• well established risk
  • pregnant women
  • premature infants (birth weight < 1200 g)
  • intrauterine transfusions
  • recipients of allogenic bone marrow transplants or stem cell transplants from seronegative donors
  • patients with HIV infection
  • recipient of a solid organ transplant from CMV seronegative donor
• risk less well established
  • patients who are potential candidates for bone marrow transplant
  • autologous bone marrow & progenitor cell transplant recipients

More general terms

• indication

Additional terms

• blood products
• blood transfusion
• cytomegalovirus (CMV, human herpesvirus 5, HHV5)